Chitosan and its salts for mucosal and transmucosal delivery
- PMID: 19637983
- DOI: 10.1517/17425240903114142
Chitosan and its salts for mucosal and transmucosal delivery
Abstract
This review considers the application of chitosan and its salts in the delivery of drugs intended to act locally towards diseases of the mucosa itself (mucosal delivery), and to undergo systemic absorption by means of transmucosal routes (transmucosal delivery). Those chitosan properties that are particularly useful in mucosal and transmucosal delivery have been reviewed, such as mucoadhesion, penetration enhancement and peptidase inhibition behaviour. Chitosan bioactive properties have also been considered, such as anti-infective, haemostatic, wound healing and immune-stimulating activity. Chitosan is available with a wide range of molecular mass and deacetylation degree: the influence of these properties on polymer performance and solubility has been taken into account. As solubility in particular can strongly limit the results obtained at pH values close to neutrality, particular attention has been paid to chitosan salts and derivatives with modified solubility. Thanks to the presence of positively charged amino groups of the polymer, a subject of increasing interest is the exploitation of its interaction with acidic molecules having potential synergistic behaviour towards bioactive properties, or even with acidic drugs. The aim of the review is to describe not only some properties of chitosan, but also the way they can be modified by the acidic moiety.
Similar articles
-
Potential applications of chitosan in veterinary medicine.Adv Drug Deliv Rev. 2004 Jun 23;56(10):1467-80. doi: 10.1016/j.addr.2004.02.007. Adv Drug Deliv Rev. 2004. PMID: 15191793 Review.
-
Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.Biomaterials. 2006 Jan;27(1):127-35. doi: 10.1016/j.biomaterials.2005.05.075. Biomaterials. 2006. PMID: 16045983
-
Improved adhesion to mucosal cells of water-soluble chitosan tetraalkylammonium salts.Int J Pharm. 2008 Oct 1;362(1-2):88-92. doi: 10.1016/j.ijpharm.2008.06.017. Epub 2008 Jun 26. Int J Pharm. 2008. PMID: 18634863
-
Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.Eur J Pharm Biopharm. 2004 Sep;58(2):225-35. doi: 10.1016/j.ejpb.2004.03.023. Eur J Pharm Biopharm. 2004. PMID: 15296951 Review.
-
Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.J Pharm Pharmacol. 2008 Sep;60(9):1111-9. doi: 10.1211/jpp.60.9.0001. J Pharm Pharmacol. 2008. PMID: 18718113 Review.
Cited by
-
Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems.Polymers (Basel). 2018 Mar 5;10(3):267. doi: 10.3390/polym10030267. Polymers (Basel). 2018. PMID: 30966302 Free PMC article. Review.
-
Structural and Functional Analysis of the Complex between Citrate and the Zinc Peptidase Carboxypeptidase A.Enzyme Res. 2011;2011:128676. doi: 10.4061/2011/128676. Epub 2011 Jul 25. Enzyme Res. 2011. PMID: 21804935 Free PMC article.
-
Novel Drug Delivery Approaches for the Localized Treatment of Cervical Cancer.AAPS PharmSciTech. 2024 Apr 11;25(4):85. doi: 10.1208/s12249-024-02801-1. AAPS PharmSciTech. 2024. PMID: 38605158 Review.
-
Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.Eur J Pharm Biopharm. 2016 Dec;109:224-235. doi: 10.1016/j.ejpb.2016.10.015. Epub 2016 Oct 25. Eur J Pharm Biopharm. 2016. PMID: 27793755 Free PMC article.
-
Preparation of chitosan-coated hollow tin dioxide nanoparticles and their application in improving the oral bioavailability of febuxostat.Int J Pharm X. 2023 Jul 13;6:100199. doi: 10.1016/j.ijpx.2023.100199. eCollection 2023 Dec 15. Int J Pharm X. 2023. PMID: 37521247 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials